Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies
✍ Scribed by Tektonidou, Maria G. ;Laskari, Katerina ;Panagiotakos, Demosthenes B. ;Moutsopoulos, Haralampos M.
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 101 KB
- Volume
- 61
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective To examine the prevalence of and risk factors for low bone mineral density (BMD) and vertebral fractures in patients with systemic lupus erythematosus (SLE). ## Methods We studied 107 SLE patients. Demographic and clinical data were collected, and radiographs of the thor
## Abstract ## Objective Patients with systemic lupus erythematosus (SLE) are significantly more likely to experience a myocardial infarction or a stroke than age‐matched controls. We compared the prevalence of conventional and lupus‐specific risk factors in patients with SLE just before a cardiov
## Abstract ## Objective Venous thrombosis is a relatively frequent and serious complication in systemic lupus erythematosus (SLE) that has been associated with the presence of antiphospholipid antibodies (aPL). However, venous thrombotic events can also be seen in patients without aPL, and only a